Manning M - Search Results

1

Selective and potent agonists and antagonists for investigating the role of mouse oxytocin receptors.

Busnelli M, Bulgheroni E, Manning M, Kleinau G, Chini B. Busnelli M, et al. Among authors: manning m. J Pharmacol Exp Ther. 2013 Aug;346(2):318-27. doi: 10.1124/jpet.113.202994. Epub 2013 May 30. J Pharmacol Exp Ther. 2013. PMID: 23723434 Free PMC article.

2

Affinity and efficacy of selective agonists and antagonists for vasopressin and oxytocin receptors: an "easy guide" to receptor pharmacology.

Chini B, Manning M, Guillon G. Chini B, et al. Among authors: manning m. Prog Brain Res. 2008;170:513-7. doi: 10.1016/S0079-6123(08)00438-X. Prog Brain Res. 2008. PMID: 18655904

3

Functional selective oxytocin-derived agonists discriminate between individual G protein family subtypes.

Busnelli M, Saulière A, Manning M, Bouvier M, Galés C, Chini B. Busnelli M, et al. Among authors: manning m. J Biol Chem. 2012 Feb 3;287(6):3617-29. doi: 10.1074/jbc.M111.277178. Epub 2011 Nov 8. J Biol Chem. 2012. PMID: 22069312 Free PMC article.

4

Design and Characterization of Superpotent Bivalent Ligands Targeting Oxytocin Receptor Dimers via a Channel-Like Structure.

Busnelli M, Kleinau G, Muttenthaler M, Stoev S, Manning M, Bibic L, Howell LA, McCormick PJ, Di Lascio S, Braida D, Sala M, Rovati GE, Bellini T, Chini B. Busnelli M, et al. Among authors: manning m. J Med Chem. 2016 Aug 11;59(15):7152-66. doi: 10.1021/acs.jmedchem.6b00564. Epub 2016 Jul 28. J Med Chem. 2016. PMID: 27420737 Free article.

5

Agonist selectivity in the oxytocin/vasopressin receptor family: new insights and challenges.

Chini B, Manning M. Chini B, et al. Among authors: manning m. Biochem Soc Trans. 2007 Aug;35(Pt 4):737-41. doi: 10.1042/BST0350737. Biochem Soc Trans. 2007. PMID: 17635137 Review.

6

Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.

Manning M, Stoev S, Chini B, Durroux T, Mouillac B, Guillon G. Manning M, et al. Prog Brain Res. 2008;170:473-512. doi: 10.1016/S0079-6123(08)00437-8. Prog Brain Res. 2008. PMID: 18655903 Review.

7

Improved radiotracing of oxytocin receptor-expressing tumours using the new [111In]-DOTA-Lys8-deamino-vasotocin analogue.

Chini B, Chinol M, Cassoni P, Papi S, Reversi A, Areces L, Marrocco T, Paganelli G, Manning M, Bussolati G. Chini B, et al. Among authors: manning m. Br J Cancer. 2003 Sep 1;89(5):930-6. doi: 10.1038/sj.bjc.6601189. Br J Cancer. 2003. PMID: 12942128 Free PMC article.

8

Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics.

Manning M, Misicka A, Olma A, Bankowski K, Stoev S, Chini B, Durroux T, Mouillac B, Corbani M, Guillon G. Manning M, et al. J Neuroendocrinol. 2012 Apr;24(4):609-28. doi: 10.1111/j.1365-2826.2012.02303.x. J Neuroendocrinol. 2012. PMID: 22375852 Free PMC article. Review.

9

Identification of agonist binding sites of vasopressin and oxytocin receptors.

Mouillac B, Chini B, Balestre MN, Jard S, Barberis C, Manning M, Tribollet E, Trumpp-Kallmeyer S, Hoflack J, Elands J, et al. Mouillac B, et al. Among authors: manning m. Adv Exp Med Biol. 1995;395:301-10. Adv Exp Med Biol. 1995. PMID: 8713980

10

Molecular basis for agonist selectivity in the vasopressin/oxytocin receptor family.

Chini B, Mouillac B, Ala Y, Balestre MN, Cotte N, Trumpp-Kallmeyer S, Hoflack J, Elands J, Hibert M, Manning M, et al. Chini B, et al. Among authors: manning m. Adv Exp Med Biol. 1995;395:321-8. Adv Exp Med Biol. 1995. PMID: 8713982

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,102 results

Search Page